Compare Orchid Chemicals with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs J.B.CHEMICALS - Comparison Results

ORCHID PHARMA LTD     Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA LTD J.B.CHEMICALS ORCHID PHARMA LTD/
J.B.CHEMICALS
 
P/E (TTM) x -0.5 16.8 - View Chart
P/BV x 0.1 2.3 5.1% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 ORCHID PHARMA LTD   J.B.CHEMICALS
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
J.B.CHEMICALS
Mar-18
ORCHID PHARMA LTD/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs194363 53.4%   
Low Rs35255 13.7%   
Sales per share (Unadj.) Rs276.5169.1 163.5%  
Earnings per share (Unadj.) Rs-79.216.6 -477.2%  
Cash flow per share (Unadj.) Rs-43.523.4 -185.6%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.6 0.0%  
Book value per share (Unadj.) Rs53.9172.5 31.3%  
Shares outstanding (eoy) m70.4583.57 84.3%   
Bonus/Rights/Conversions ESOPBB-  
Price / Sales ratio x0.41.8 22.7%   
Avg P/E ratio x-1.418.6 -7.8%  
P/CF ratio (eoy) x-2.613.2 -20.0%  
Price / Book Value ratio x2.11.8 118.5%  
Dividend payout %012.0 0.0%   
Avg Mkt Cap Rs m8,06725,827 31.2%   
No. of employees `0002.83.8 74.2%   
Total wages/salary Rs m2,5272,511 100.6%   
Avg. sales/employee Rs Th6,956.13,747.4 185.6%   
Avg. wages/employee Rs Th902.5665.7 135.6%   
Avg. net profit/employee Rs Th-1,993.0367.8 -541.9%   
INCOME DATA
Net Sales Rs m19,47714,135 137.8%  
Other income Rs m407366 111.3%   
Total revenues Rs m19,88414,501 137.1%   
Gross profit Rs m1,1032,178 50.6%  
Depreciation Rs m2,519570 442.2%   
Interest Rs m5,22735 14,976.5%   
Profit before tax Rs m-6,2361,940 -321.5%   
Minority Interest Rs m200-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m5110-   
Tax Rs m-125552 -22.7%   
Profit after tax Rs m-5,5801,387 -402.3%  
Gross profit margin %5.715.4 36.7%  
Effective tax rate %2.028.5 7.1%   
Net profit margin %-28.79.8 -291.9%  
BALANCE SHEET DATA
Current assets Rs m11,01410,470 105.2%   
Current liabilities Rs m32,0602,749 1,166.3%   
Net working cap to sales %-108.154.6 -197.8%  
Current ratio x0.33.8 9.0%  
Inventory Days Days9555 171.9%  
Debtors Days Days3478 43.2%  
Net fixed assets Rs m29,4405,811 506.6%   
Share capital Rs m705167 421.6%   
"Free" reserves Rs m2,04314,248 14.3%   
Net worth Rs m3,80014,416 26.4%   
Long term debt Rs m9,0180-   
Total assets Rs m46,51017,649 263.5%  
Interest coverage x-0.256.6 -0.3%   
Debt to equity ratio x2.40-  
Sales to assets ratio x0.40.8 52.3%   
Return on assets %-0.88.1 -9.4%  
Return on equity %-146.99.6 -1,526.1%  
Return on capital %-3.713.7 -27.3%  
Exports to sales %37.90-   
Imports to sales %22.60-   
Exports (fob) Rs m7,378NA-   
Imports (cif) Rs m4,406NA-   
Fx inflow Rs m7,5136,164 121.9%   
Fx outflow Rs m5,6491,334 423.3%   
Net fx Rs m1,8654,829 38.6%   
CASH FLOW
From Operations Rs m1,6821,231 136.7%  
From Investments Rs m-9,860-208 4,738.3%  
From Financial Activity Rs m6,644-595 -1,116.2%  
Net Cashflow Rs m-1,535427 -359.4%  

Share Holding

Indian Promoters % 32.3 55.4 58.3%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 4.6 3.4 135.7%  
FIIs % 3.3 3.9 84.6%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 37.0 149.5%  
Shareholders   84,811 30,437 278.6%  
Pledged promoter(s) holding % 54.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA LTD With:   PLETHICO PHARMA  BIOCON   FULFORD INDIA  ALKEM LABORATORIES  DIVIS LABORATORIES  

Compare ORCHID PHARMA LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Jumps 1,921 Points, FM's Tax Relief, and Top Cues in Focus Today(Pre-Open)

Share markets in India jumped sharply on Friday after Finance Minister Nirmala Sitharaman announced a slew of measures in her media briefing ahead of the GST Council meet.

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8% (Quarterly Result Update)

Aug 24, 2018 | Updated on Aug 24, 2018

For the quarter ended March 2018, ORCHID PHARMA LTD has posted a net profit of Rs 924 m (up 50.8% YoY). Sales on the other hand came in at Rs 2 bn (down 24.0% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

My 7 Stocks to Buy Are Companies Which Will Be a Big Part of New India(The 5 Minute Wrapup)

Sep 19, 2019

The India we knew is changing. Here's how you can benefit from this change.

Did the Tax Bonanza Really Deserve a 2,000-point Gain on the Sensex?(Profit Hunter)

Sep 20, 2019

Are investors overdoing their euphoria post the corporate tax cut bonanza?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Jul 24, 2019 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD 5-YR ANALYSIS

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS